Cost-Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands

heart failureValue in Health

Dec 14

Written By Matthijs Versteegh

Heart failure

Matthijs Versteegh

Doelmatige gezondheidszorg: hoe besteden we onze euro’s het beste?

The Risk in Avoiding Risk: Optimizing Decision Making in Structural Heart Disease Interventions